Previous Article | Next Article ![]()
Infection and Immunity, August 2004, p. 4891-4894, Vol. 72, No. 8
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.8.4891-4894.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Microbiology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia,1 Laboratory of Bacteriology and Medical Mycology, Istituto Superiore di Sanità, Rome, Italy2
Received 19 December 2003/ Returned for modification 15 March 2004/ Accepted 6 May 2004
The role of nitric oxide in group B Streptococcus (GBS) infection was evaluated by inhibiting its production with aminoguanidine (AG). AG-treated mice displayed higher mortality rates and more frequent and severe arthritis than controls. Worsening of arthritis correlated with a higher number of GBS cells in the joints and local interleukin-1ß production.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»